GMRE CEO buys 4,093 and 5,907 post-split shares on Form 4

Global Medical REIT Inc. (GMRE) reported insider share purchases by its CEO, President and Director on a Form 4.

Rhea-AI Filing Summary

Global Medical REIT Inc. (GMRE) reported insider share purchases by its CEO, President and Director on a Form 4. On 11/14/2025, the executive bought 4,093 shares of common stock at $32.41 per share and another 5,907 shares at $32.70 per share in open-market purchases. Following these transactions, the executive beneficially owns 44,774 shares directly and 3,404 shares indirectly through a spouse. The filing explains that the share amounts are presented on a post-split basis after a 1-for-5 reverse stock split completed on September 19, 2025, which also involved cash in lieu of a fractional share.

Insider Trade Summary

Net Buyer: 10,000 shares

Net Buy 3 txns

Insider Decker Mark Okey Jr

Role CEO and President

Bought 10,000 shs ($326K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	4,093	$32.41	$133K
Purchase	Common Stock	5,907	$32.70	$193K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 44,774 shares (Direct); Common Stock — 3,404 shares (Indirect, By Spouse)

Footnotes (1)

1. F1. Shares are reflected on a post-split basis in accordance with the 1-for-5 reverse stock split of the Issuer's issued and outstanding shares of common stock completed on September 19, 2025, including the Reporting Person's receipt of cash in lieu of a fractional share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GMRE report on this Form 4?

The filing shows that GMRE's CEO, President and Director purchased 4,093 shares at $32.41 and 5,907 shares at $32.70 of Global Medical REIT Inc. common stock on 11/14/2025.

How many GMRE shares does the reporting person own after the transactions?

After the reported purchases, the insider beneficially owns 44,774 shares of GMRE common stock directly and 3,404 shares indirectly through a spouse.

What is the relationship of the reporting person to Global Medical REIT Inc. (GMRE)?

The reporting person is a Director and an Officer of GMRE, serving as CEO and President.

Were GMRE share amounts adjusted for a reverse stock split?

Yes. The filing states that all share amounts are on a post-split basis following a 1-for-5 reverse stock split of GMRE common stock completed on September 19, 2025.

Does the GMRE Form 4 disclose any derivative securities transactions?

No derivative securities transactions are listed in Table II; the reported activity involves only common stock in Table I.

How is the spouse’s ownership in GMRE reported on this Form 4?

The filing reports 3,404 shares of GMRE common stock held indirectly by the insider, described as held by spouse.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/17/2025 - 08:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Decker Mark Okey Jr

(Last) (First) (Middle)

7373 WISCONSIN AVENUE, SUITE 800

(Street)

BETHESDA MD 20814

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Global Medical REIT Inc. [ GMRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/14/2025		P		4,093	A	$32.41	38,867(1)	D
Common Stock	11/14/2025		P		5,907	A	$32.7	44,774(1)	D
Common Stock								3,404(1)	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares are reflected on a post-split basis in accordance with the 1-for-5 reverse stock split of the Issuer's issued and outstanding shares of common stock completed on September 19, 2025, including the Reporting Person's receipt of cash in lieu of a fractional share.

	/s/ Jamie Barber, as Attorney-in-Fact	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.